Loading...
Current Overview on Hypercoagulability in COVID-19
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as coagulopathy, prompting a desperate need for effective management. COVID-19-associated coagulopathy (CAC) can cause various thromboem...
Na minha lista:
| Udgivet i: | Am J Cardiovasc Drugs |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398761/ https://ncbi.nlm.nih.gov/pubmed/32748336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00431-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|